Valuation : Tellgen Corporation

Market Cap 2.77B 412M 355M 334M 305M 571M 38.94B 572M 3.95B 1.53B 19.98B 1.55B 1.51B 64.36B P/E 2024
66.3x
P/E 2025 836x
Enterprise Value 2.56B 381M 328M 309M 282M 527M 35.98B 529M 3.65B 1.41B 18.46B 1.43B 1.4B 59.47B EV / Sales 2024
4.21x
EV / Sales 2025 7.5x
Free-Float
66.27%
Yield 2024
1.06%
Yield 2025 0.54%
1 day-5.51%
1 week-8.07%
Current month+2.12%
1 month+34.26%
3 months+32.52%
6 months+2.36%
Current year-5.82%
1 week 16.05
Extreme 16.05
20.35
1 month 12.63
Extreme 12.63
20.35
Current year 11.04
Extreme 11.04
22.87
1 year 11.04
Extreme 11.04
30
3 years 9.94
Extreme 9.94
32.8
5 years 9.94
Extreme 9.94
42.68
10 years 9.94
Extreme 9.94
50.25
Manager TitleAgeSince
Chief Executive Officer 56 06/11/2003
Director of Finance/CFO 50 09/06/2023
Corporate Officer/Principal 44 01/04/2009
Director TitleAgeSince
Chairman 56 06/11/2003
Director/Board Member 44 09/12/2020
Director/Board Member 63 14/08/2019
Change 5-day change 1-year change 3-year change Capi.($)
-5.51%-8.07%-39.25%-7.28% 412M
+0.23%-0.06%+163.05%+361.04% 21.66B
-2.24%-1.33%-35.83%-22.38% 10.16B
-0.90%+1.80%+361.68%+15.91% 8.16B
-0.99%-2.18%-31.03% - 7.08B
-0.01%+0.20%+87.61%+50.03% 6.59B
+2.34%-1.27%-20.56%-16.40% 6.03B
-1.82%-1.64%-8.72%-21.79% 4.33B
-0.62%-0.38%+76.78%+83.40% 4.22B
+1.82%-0.27%-18.22%-29.00% 2.81B
Average -0.77%-0.17%+53.55%+45.95% 7.15B
Weighted average by Cap. -0.36%-0.25%+91.98%+126.25%

Financials

2024 2025
Net sales 437M 65.06M 55.98M 52.67M 48.12M 90.01M 6.14B 90.26M 622M 242M 3.15B 244M 239M 10.15B 364M 54.19M 46.63M 43.88M 40.08M 74.98M 5.12B 75.18M 518M 201M 2.63B 203M 199M 8.46B
Net income 34.53M 5.14M 4.43M 4.16M 3.8M 7.12M 486M 7.14M 49.21M 19.1M 249M 19.32M 18.9M 803M 3.59M 534K 460K 433K 395K 739K 50.46M 741K 5.11M 1.98M 25.89M 2.01M 1.96M 83.4M
Net Debt -434M -64.68M -55.66M -52.37M -47.84M -89.49M -6.11B -89.73M -619M -240M -3.13B -243M -238M -10.09B -210M -31.33M -26.96M -25.37M -23.17M -43.35M -2.96B -43.47M -300M -116M -1.52B -118M -115M -4.89B
Logo Tellgen Corporation
Tellgen Corporation is a China-based company primarily engaged in the research and development, production and sales of in vitro diagnostic products. The Company's products mainly cover the fields of immunity, molecules and biochemistry, involving autoimmunity, tumors, cardiovascular, infection, hormones, metabolism and other fields. The Company's main products include tumor marker detection products, human papillomavirus (HPV) nucleic acid detection products, autoimmune disease detection products, methylation mutation detection products and other products. The Company conducts its business in the domestic and overseas markets.
Employees
683
Date Price Change Volume
04/09/26 CN¥17.32 -5.51% 29,915,210
03/09/26 CN¥18.33 -4.53% 29,354,160
02/09/26 CN¥19.20 -5.65% 37,109,901
01/09/26 CN¥20.35 +19.99% 43,152,343
31/08/26 CN¥16.96 -9.98% 30,571,152

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 300642 Stock